Irbesartan Zentiva (Irbesartan)

Irbesartan blocks the angiotensin II type 1 (AT1) receptors, preventing the hormone angiotensin II from causing blood vessels to narrow and the adrenal glands from releasing aldosterone. This results in vasodilation, reduced fluid retention, and lower blood pressure, while also protecting kidney function.

The appropriate dose of Irbesartan Zentiva is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Irbesartan is generally not recommended during pregnancy because it can affect fetal development. Safety during breastfeeding has not been fully established, so the prescriber will weigh potential benefits against risks before recommending use in nursing mothers.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Irbesartan belongs to the ARB class, which offers blood‑pressure control similar to ACE inhibitors but with a lower incidence of cough and angioedema. Compared with calcium‑channel blockers, ARBs target the renin‑angiotensin system rather than calcium channels, providing an alternative mechanism for patients who need additional or alternative therapy.

Irbesartan Zentiva should be stored at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Irbesartan Zentiva is taken orally, usually once daily with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare provider.

Serious risks include angioedema, which can cause swelling of the face or throat and may impair breathing, and hyperkalemia, an elevated potassium level that can affect heart rhythm. Acute kidney injury is another rare but important concern, especially when used with other nephrotoxic drugs.

Individuals with known hypersensitivity to irbesartan or any other ARB should avoid this medication. It is also contraindicated in patients with severe hepatic impairment or those taking certain medications, such as aliskiren in diabetic patients, due to increased risk of adverse effects.